Ads
related to: immuno-oncology- 4 stage cancer
Modern treatment in Germany
New effective methods
- Prof. Dr. Frank Gansauge
LDG Lab Director, Head Physician of
Oncology and D-Cell Therapy Dept
- Questions & Answers
Where to begin? How choose clinic?
How much does it cost? We will help
- Ask Doctor Online - 250€
Consultation with Dr Frank Gansauge
Discount from regular price 1500€
- Leading clinics. Germany
Treatment organization from A to Z
We will help you to avoid mistakes!
- Exclusive Service
Individual consultations
24/7 patient support
- 4 stage cancer
Search results
Theriva Biologics Receives Fast Track Designation From FDA For VCN-01 For Treating Metastatic...
Benzinga· 6 days agoTheriva™ Biologics TOVX is an immuno-oncology company developing oncolytic viruses, otherwise known...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 4 days agoCalyx / Invicro Forges a Strategic Collaboration with BAMF Health to Accelerate Clinical Translation of Radioligand Therapies and Immuno-Oncology Agents ...
Brokerages Set Precigen, Inc. (NASDAQ:PGEN) Target Price at $10.00
ETF DAILY NEWS· 5 hours agoPrecigen, Inc. (NASDAQ:PGEN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the five brokerages that are currently covering the stock, MarketBeat.com reports ...
HC Wainwright Reiterates Buy Rating for ALX Oncology (NASDAQ:ALXO)
ETF DAILY NEWS· 5 hours agoALX Oncology (NASDAQ:ALXO – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued on Monday, Benzinga reports. HC Wainwright’s price target suggests ...
Fundraiser for Pelotonia to Take Place at the Downtown Exchange - WHIZ - Fox 5 / Marquee...
WHIZ News Zanesville· 13 hours agoJames Cancer Hospital and Richard J. Solove Research Institute, and the Pelotonia Institute for ...
Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024
Morningstar· 7 days agoAffimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced ...
This Needham biotech's stock has gone up 700% in 3 months - Boston Business Journal
The Business Journals· 2 days agoPaul Peter Tak, CEO of the immuno-oncology company, recently sat down with the Business Journal to...
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
Morningstar· 6 days agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA-3705 for the Support for Clinical Trials ...
Agenus (NASDAQ:AGEN) Stock Crosses Above 200-Day Moving Average of $12.95
ETF DAILY NEWS· 1 day agoAgenus Inc. (NASDAQ:AGEN – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $12.95 and traded as high as $17.65.
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
Motley Fool via Yahoo Finance· 3 days agoAnd it's key because it represents a source of revenue. Meanwhile, CRISPR Therapeutics is moving...
Ad
related to: immuno-oncology
